[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339944-105":59,"doc-detail-339944-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","expression-and-clinical-significance-of-cldn7-and-its-immune-related-cells-in-breast-cancer-research-open-access","Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer - Research Open Access","","Tight junctions (TJs) rely on claudins (CLDNs), and abnormal CLDN expression is frequently observed across epithelial-origin tumors. While CLDN7 has been linked to metastasis and altered outcomes in several cancers, its expression pattern and prognostic meaning in breast cancer (BC) remain unclear. This study evaluates CLDN7 expression together with immune-related factors to clarify biological links and guide improved therapeutic strategies for BC patients.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-and-clinical-significance-of-cldn7-and-its-immune-related-cells-in-breast-cancer-research-open-access/339944/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-and-clinical-significance-of-cldn7-and-its-immune-related-cells-in-breast-cancer-research-open-access/339944.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of investigating CLDN7 in breast cancer?","Question",{"text":113,"@type":114},"To determine CLDN7’s expression pattern in breast cancer and clarify how CLDN7-related immune factors may influence prognosis and therapeutic opportunities.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study assess CLDN7 expression and its clinical relevance?",{"text":118,"@type":114},"It used cBioPortal, GEPIA, and TCGA for expression analysis, Kaplan-Meier Plotter for survival associations, and immunohistochemical staining on 92 breast cancer tissues and 20 benign breast tumor samples for validation.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationship did the study find between CLDN7 overexpression and immune cell activity?",{"text":122,"@type":114},"CLDN7 overexpression was negatively associated with the activation of B-cells, CD4+ T-cells, and CD8+ T-cells, while it was positively associated with M0 macrophages.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339944,1790957233,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Fan etal. Diagnostic Pathology (2024) 19:113 [https://doi.org/10.1186/s13000-024-01513-1](https://doi.org/10.1186/s13000-024-01513-1)  \nDiagnostic Pathology  \nRESEARCH Open Access  \nExpression and clinical significance of CLDN7 and its immune-related cells in breast cancer  \nXiaojie Fan 1, Aifeng Qi2, Meng Zhang 1, Ying Jia 1, Shi Li 1, Dandan Han 1 and Yueping Liu 1*  \nAbstract  \nBackground CLDN is a core component of tight junctions (TJs) . Abnormal expressions of CLDNs are commonly detected in various types of tumors. CLDNs are of interest as a potential therapeutic target. CLDNs are closely associated with most cancers of epithelial origin, especially when CLDN7 promotes cancer cell metastasis, such as in gastric, cervical, and ovarian cancers. Its expression and prognosis in breast cancer (BC) remain unknown.The purpose of this study was to investigate the expression pattern of CLDN7 and related immune factors in BC and shed light on abetter therapeutic avenue for BC patients.  \nMethod The cBioPortal, GEPIA, and TCGA databases were used to comprehensively assess the expression of CLDN7 in BC. The Kaplan-Meier Plotter (KMP) database was applied to examine the relationship among the CLDN7 overexpression (OE), prognosis, and overall survival (OS) of BC patients. Immunohistochemical staining was performed on 92 BC tissue samples and 20 benign breast tumors to verify the expression level of CLDN-7 protein and its correlation with clinicopathological features and prognosis. TIMER2 .0 was used to analyze the correlation between the CLDN7 OE and immune gene activation using BC-related transcriptomic data. Enrichment analyses of CLDN7-related immune pathways were conducted using online databases. The risk of expression of CLDN7-related immune genes was assessed and differential ly expressed (DE) genes were included in the construction of the risk prognosis nomogram.  \nResults Both database analysis and clinical sample validation results showed that CLDN7 was significantly overexpressed (OE) in BC, and the OE was correlated with poor DFS in BC patients (p \u003C 0. 05) . TIMER2 .0 analysis indicated that CLDN7 OE was negatively associated with the activation of B-cells, CD4+ T-cells, and CD8+ T-cells but positively with the M0 macrophages. Pathway enrichment analysis suggested that CLDN7-related immune factors were mostly involved in the NF-κB and T-cell receptor (TCR) signaling pathways. Univariate Cox regression was used to analyze the correlation between 52 CLDN7 related genes and OS, and 22 genes that are related to prognosis were identified. Prognostic genes were included in the prognostic nomogram of BC with a C-index of 0.76 to predict the 3-year and 5-year OS probabilities of BC individuals.  \nConclusions These findings provide evidence for the role of CLDN7-linked tumor immunity, suggesting that CLDN7 might be a potential immunotherapeutic target for BC, and its association with immune markers could shed light on the better prognosis of BC.  \nKeywords Breast cancer, Tumor immune cell infiltration, Prognosis, CLDN7, Expression  \n*Correspondence: Yueping Liu [liuyp@hbmu.edu](liuyp@hbmu.edu)  \n1Departments of Pathology, the Fourth Hospital of Hebei Medical University, No. 12, Jiankang Road, Shijiazhuang 050011, PR China 2Shijiazhuang Hospital of Traditional Chinese Medicine, No. 233, zhongshan Road, Shijiazhuang 050011, PR China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative C","cbCait19JYBb59RF","https://ap.wps.com/l/cbCait19JYBb59RF","pdf",5906556,15,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main purpose of investigating CLDN7 in breast cancer?\",\"answer\":\"To determine CLDN7’s expression pattern in breast cancer and clarify how CLDN7-related immune factors may influence prognosis and therapeutic opportunities.\"},{\"question\":\"How did the study assess CLDN7 expression and its clinical relevance?\",\"answer\":\"It used cBioPortal, GEPIA, and TCGA for expression analysis, Kaplan-Meier Plotter for survival associations, and immunohistochemical staining on 92 breast cancer tissues and 20 benign breast tumor samples for validation.\"},{\"question\":\"What relationship did the study find between CLDN7 overexpression and immune cell activity?\",\"answer\":\"CLDN7 overexpression was negatively associated with the activation of B-cells, CD4+ T-cells, and CD8+ T-cells, while it was positively associated with M0 macrophages.\"}]","Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer - Research Open Access | PDF",1790033232,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/238818bc4cafdf3a0f0021918433c02a.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2efd84d015a55b80f5b390204d4e0c5b.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b300238a0e6779485686b8637ef3d13a.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74dff4541a952a1c998b5454ce2922fc.webp",980,1306]